Posted by Michael Wonder on 12 Nov 2020
Proposal to widen access to valganciclovir for transplant patients
12 November 2020 - PHARMAC is seeking feedback on a proposal to widen access to valganciclovir.
PHARMAC is seeking feedback on a proposal to widen access to valganciclovir for use after lung transplant and for patients who require further cytomegalovirus prophylaxis following pulse methylprednisolone treatment following transplant.
